GlassScriptPhysician profile
Kathryn Young
NPI 1164668349
$1,139.41
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2022: $244 · 2023: $360 · 2024: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.24 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $332.68 | 2021-2024 | Veozah |
| Abbvie INC. | $255.14 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $96.61 | 2023-2024 | Myfembree, Gemtesa |
| Pfizer INC. | $93.60 | 2021-2024 | |
| Exact Sciences Corporation | $87.38 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $45.48 | 2021-2023 | Gardasil 9 |
| Agile Therapeutics, INC. | $44.52 | 2022-2023 | Twirla |
| Exeltis, USA INC. | $26.96 | 2022-2023 | Slynd |
| Sage Therapeutics, LLC | $26.18 | 2024 | |
| Hologic Sales and Service, LLC | $25.99 | 2021-2022 | |
| Organon LLC | $17.01 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.50 | 2022 | |
| Amgen INC. | $15.49 | 2022 | |
| Evofem Biosciences, INC. | $15.48 | 2022 | |
| Myovant Sciences INC. | $14.59 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $13.53 | 2023 | Auvelity |
| Avion Pharmaceuticals | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.